These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7587752)

  • 21. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J; López-Karpovitch X; Cárdenas MR
    Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
    Klujber V; Koós R; Schuler D; Bocsi J
    Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunophenotyping of leukemia: overview].
    Huber K; Worofka B; Kittl E; Tomasits J; Hofmann J; Bauer K
    Wien Klin Wochenschr; 1994; 106(8):226-30. PubMed ID: 8023514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients.
    Unal S; Cetin M; Tuncer AM; Gümrük F; Yetgin S
    Turk J Pediatr; 2008; 50(6):533-6. PubMed ID: 19227415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
    Marinov J; Koubek K; Starý J
    Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
    Zwick D; Cooley L; Hetherington M
    Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital leukemia: comprehensive nursing care for a rare disease: a case study.
    Embon CM; Goldstein KL; Hall MR; Leu BB; Saboe G; Smith BA
    Neonatal Netw; 1995 Sep; 14(6):7-14. PubMed ID: 7659067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry. Clinical and research applications in hematologic malignancies.
    Huh YO; Andreeff M
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):703-23. PubMed ID: 7961287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.
    Willman CL
    Mod Pathol; 1999 Feb; 12(2):218-28. PubMed ID: 10071344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary aleukemic myeloid leukemia cutis treated successfully with combination chemotherapy: report of a case and review of the literature.
    Chang H; Shih LY; Kuo TT
    Ann Hematol; 2003 Jul; 82(7):435-9. PubMed ID: 12768324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance.
    Bahia DM; Yamamoto M; Chauffaille Mde L; Kimura EY; Bordin JO; Filgueiras MA; Kerbauy J
    Haematologica; 2001 Aug; 86(8):801-6. PubMed ID: 11522535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
    Piedras J; Barrales-Benítez O; López-Karpovitch X
    Rev Invest Clin; 2000; 52(5):524-8. PubMed ID: 11195181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: genetic and morphologic correlates.
    Bagg A
    Am J Clin Pathol; 2007 Oct; 128(4):545-8. PubMed ID: 17875503
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunophenotyping leukemias: the new force in hematology.
    Sullivan JG; Wiggers TB
    Clin Lab Sci; 2000; 13(2):117-22. PubMed ID: 11066450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of quartz-crystal-microbalance-based immunosensor array for clinical immunophenotyping of acute leukemias.
    Zeng H; Wang H; Chen F; Xin H; Wang G; Xiao L; Song K; Wu D; He Q; Shen G
    Anal Biochem; 2006 Apr; 351(1):69-76. PubMed ID: 16455039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia.
    Sato N; Kishi K; Toba K; Watanabe K; Itoh H; Narita M; Takahashi M; Aizawa Y
    Leuk Res; 2004 Jul; 28(7):691-8. PubMed ID: 15158090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural network analysis of flow cytometry immunophenotype data.
    Kothari R; Cualing H; Balachander T
    IEEE Trans Biomed Eng; 1996 Aug; 43(8):803-10. PubMed ID: 9216152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.